MARLTON, N.J., Impulse Dynamics has announced the completion of a $101 million financing round comprised of both equity and debt.
Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce today the completion of a $101 million financing round comprised of both equity and debt. Participants include new investors, Alger and Squarepoint Capital LLC; existing investors, Abiomed, Inc. and Kennedy Lewis Investment Management LLC; and private investors from the company's Board of Directors, including the company's CEO, Simos Kedikoglou, MD.
Impulse Dynamics is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company pioneered CCMÂ® therapy, which is delivered by the company's OptimizerÂ® Smart system, an FDA-approved treatment verified to improve the quality of life for heart failure patients. CCM therapy is a safe and effective minimally invasive treatment option for many heart failure patients who otherwise have few effective alternatives available to them.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about